Literature DB >> 25195186

Low-grade gliomas: the challenges of imaging.

R Guillevin1, G Herpe2, M Verdier2, C Guillevin2.   

Abstract

WHO grade II gliomas are a major challenge for magnetic resonance imaging (MRI) due to their delayed anaplastic transformation. Today it is possible to individually characterize tumor progression from diagnosis to anaplastic transformation based on the many parameters identified in studies in the literature and the possibility of integrating these data into mathematical models. Early identification of negative morphological and metabolic factors, as well as treatment follow-up, help identify predictive factors of tumor progression, as well as determine treatment response to adapt management of this disease.
Copyright © 2014 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Low-grade gliomas; MRI; Perfusion imaging; Spectroscopy; Therapeutic follow-up

Mesh：

Year:  2014        PMID： 25195186     DOI： 10.1016/j.diii.2014.07.005

Source DB:  PubMed          Journal:  Diagn Interv Imaging        ISSN： 2211-5684            Impact factor:   4.026


  9 in total

1.  Pseudo-insular glioma syndrome: illustrative cases.

Authors:  Alexander F Haddad; Jacob S Young; Ramin A Morshed; S Andrew Josephson; Soonmee Cha; Mitchel S Berger
Journal:  J Neurosurg Case Lessons       Date:  2021-12-27

2.  The diagnostic value of contrast enhancement on MRI in diffuse and anaplastic gliomas.

Authors:  Aleksandrs Krigers; Matthias Demetz; Astrid E Grams; Claudius Thomé; Christian F Freyschlag
Journal:  Acta Neurochir (Wien)       Date:  2022-01-11       Impact factor: 2.816

Review 3.  Surgical Neuro-Oncology: Management of Glioma.

Authors:  Dana Mitchell; Jack M Shireman; Mahua Dey
Journal:  Neurol Clin       Date:  2022-03-31       Impact factor: 3.787

4.  Efficiency of High and Standard b Value Diffusion-Weighted Magnetic Resonance Imaging in Grading of Gliomas.

Authors:  Mansour Al-Agha; Khaled Abushab; Khetam Quffa; Samy Al-Agha; Yasser Alajerami; Mohammed Tabash
Journal:  J Oncol       Date:  2020-09-14       Impact factor: 4.375

5.  The Use of MR Perfusion Imaging in the Evaluation of Tumor Progression in Gliomas.

Authors:  Brian Snelling; Ashish H Shah; Simon Buttrick; Ronald Benveniste
Journal:  J Korean Neurosurg Soc       Date:  2016-12-29

6.  Imaging Hyperpolarized Pyruvate and Lactate after Blood-Brain Barrier Disruption with Focused Ultrasound.

Authors:  Tom H Peeters; Thiele Kobus; Vincent Breukels; Krissie Lenting; Andor Veltien; Arend Heerschap; Tom W J Scheenen
Journal:  ACS Chem Neurosci       Date:  2019-03-26       Impact factor: 4.418

Review 7.  Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics.

Authors:  Artemiy S Silantyev; Luca Falzone; Massimo Libra; Olga I Gurina; Karina Sh Kardashova; Taxiarchis K Nikolouzakis; Alexander E Nosyrev; Christopher W Sutton; Panayiotis D. Mitsias; Aristides Tsatsakis
Journal:  Cells       Date:  2019-08-09       Impact factor: 6.600

Review 8.  Receptor-Targeted Glial Brain Tumor Therapies.

Authors:  Puja Sharma; Waldemar Debinski
Journal:  Int J Mol Sci       Date:  2018-10-25       Impact factor: 5.923

9.  Clinical, radiological and molecular characterization of intramedullary astrocytomas.

Authors:  Laetitia Lebrun; Barbara Meléndez; Oriane Blanchard; Nancy De Nève; Claude Van Campenhout; Julie Lelotte; Danielle Balériaux; Matteo Riva; Jacques Brotchi; Michaël Bruneau; Olivier De Witte; Christine Decaestecker; Nicky D'Haene; Isabelle Salmon
Journal:  Acta Neuropathol Commun       Date:  2020-08-08       Impact factor: 7.801
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.